243 related articles for article (PubMed ID: 12013531)
1. The role of osteopontin in breast cancer: clinical and experimental studies.
Tuck AB; Chambers AF
J Mammary Gland Biol Neoplasia; 2001 Oct; 6(4):419-29. PubMed ID: 12013531
[TBL] [Abstract][Full Text] [Related]
2. Osteopontin-induced migration of human mammary epithelial cells involves activation of EGF receptor and multiple signal transduction pathways.
Tuck AB; Hota C; Wilson SM; Chambers AF
Oncogene; 2003 Feb; 22(8):1198-205. PubMed ID: 12606946
[TBL] [Abstract][Full Text] [Related]
3. Beta(3) integrin expression increases breast carcinoma cell responsiveness to the malignancy-enhancing effects of osteopontin.
Furger KA; Allan AL; Wilson SM; Hota C; Vantyghem SA; Postenka CO; Al-Katib W; Chambers AF; Tuck AB
Mol Cancer Res; 2003 Sep; 1(11):810-9. PubMed ID: 14517343
[TBL] [Abstract][Full Text] [Related]
4. Osteopontin-induced, integrin-dependent migration of human mammary epithelial cells involves activation of the hepatocyte growth factor receptor (Met).
Tuck AB; Elliott BE; Hota C; Tremblay E; Chambers AF
J Cell Biochem; 2000 Jun; 78(3):465-75. PubMed ID: 10861844
[TBL] [Abstract][Full Text] [Related]
5. The functional and clinical roles of osteopontin in cancer and metastasis.
Furger KA; Menon RK; Tuck AB; Bramwell VH; Chambers AF
Curr Mol Med; 2001 Nov; 1(5):621-32. PubMed ID: 11899236
[TBL] [Abstract][Full Text] [Related]
6. Osteopontin induces increased invasiveness and plasminogen activator expression of human mammary epithelial cells.
Tuck AB; Arsenault DM; O'Malley FP; Hota C; Ling MC; Wilson SM; Chambers AF
Oncogene; 1999 Jul; 18(29):4237-46. PubMed ID: 10435636
[TBL] [Abstract][Full Text] [Related]
7. Osteopontin: it's role in regulation of cell motility and nuclear factor kappa B-mediated urokinase type plasminogen activator expression.
Das R; Philip S; Mahabeleshwar GH; Bulbule A; Kundu GC
IUBMB Life; 2005 Jun; 57(6):441-7. PubMed ID: 16012053
[TBL] [Abstract][Full Text] [Related]
8. Integrin-linked kinase regulates osteopontin-dependent MMP-2 and uPA expression to convey metastatic function in murine mammary epithelial cancer cells.
Mi Z; Guo H; Wai PY; Gao C; Kuo PC
Carcinogenesis; 2006 Jun; 27(6):1134-45. PubMed ID: 16474180
[TBL] [Abstract][Full Text] [Related]
9. Elevated plasma osteopontin in metastatic breast cancer associated with increased tumor burden and decreased survival.
Singhal H; Bautista DS; Tonkin KS; O'Malley FP; Tuck AB; Chambers AF; Harris JF
Clin Cancer Res; 1997 Apr; 3(4):605-11. PubMed ID: 9815727
[TBL] [Abstract][Full Text] [Related]
10. Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancer.
Allan AL; George R; Vantyghem SA; Lee MW; Hodgson NC; Engel CJ; Holliday RL; Girvan DP; Scott LA; Postenka CO; Al-Katib W; Stitt LW; Uede T; Chambers AF; Tuck AB
Am J Pathol; 2006 Jul; 169(1):233-46. PubMed ID: 16816376
[TBL] [Abstract][Full Text] [Related]
11. Osteopontin overexpression in breast cancer: knowledge gained and possible implications for clinical management.
Tuck AB; Chambers AF; Allan AL
J Cell Biochem; 2007 Nov; 102(4):859-68. PubMed ID: 17721886
[TBL] [Abstract][Full Text] [Related]
12. Osteopontin knockdown inhibits αv,β3 integrin-induced cell migration and invasion and promotes apoptosis of breast cancer cells by inducing autophagy and inactivating the PI3K/Akt/mTOR pathway.
Zhang H; Guo M; Chen JH; Wang Z; Du XF; Liu PX; Li WH
Cell Physiol Biochem; 2014; 33(4):991-1002. PubMed ID: 24714122
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of endothelial cell migration by vascular permeability factor/vascular endothelial growth factor through cooperative mechanisms involving the alphavbeta3 integrin, osteopontin, and thrombin.
Senger DR; Ledbetter SR; Claffey KP; Papadopoulos-Sergiou A; Peruzzi CA; Detmar M
Am J Pathol; 1996 Jul; 149(1):293-305. PubMed ID: 8686754
[TBL] [Abstract][Full Text] [Related]
14. Transforming JB6 cells exhibit enhanced integrin-mediated adhesion to osteopontin.
Chang PL; Chambers AF
J Cell Biochem; 2000 Apr; 78(1):8-23. PubMed ID: 10797562
[TBL] [Abstract][Full Text] [Related]
15. Osteopontin regulates multiple functions contributing to human colon cancer development and progression.
Irby RB; McCarthy SM; Yeatman TJ
Clin Exp Metastasis; 2004; 21(6):515-23. PubMed ID: 15679049
[TBL] [Abstract][Full Text] [Related]
16. Differential gene expression of TGF-beta family members and osteopontin in breast tumor tissue: analysis by real-time quantitative PCR.
Reinholz MM; Iturria SJ; Ingle JN; Roche PC
Breast Cancer Res Treat; 2002 Jun; 74(3):255-69. PubMed ID: 12206515
[TBL] [Abstract][Full Text] [Related]
17. Osteopontin induces multiple changes in gene expression that reflect the six "hallmarks of cancer" in a model of breast cancer progression.
Cook AC; Tuck AB; McCarthy S; Turner JG; Irby RB; Bloom GC; Yeatman TJ; Chambers AF
Mol Carcinog; 2005 Aug; 43(4):225-36. PubMed ID: 15864800
[TBL] [Abstract][Full Text] [Related]
18. Osteopontin and p53 expression are associated with tumor progression in a case of synchronous, bilateral, invasive mammary carcinomas.
Tuck AB; O'Malley FP; Singhal H; Tonkin KS; Harris JF; Bautista D; Chambers AF
Arch Pathol Lab Med; 1997 Jun; 121(6):578-84. PubMed ID: 9199622
[TBL] [Abstract][Full Text] [Related]
19. Expression pattern of osteopontin in endometrial carcinoma: correlation with expression of the adhesion molecule CEACAM1.
Briese J; Schulte HM; Bamberger CM; Löning T; Bamberger AM
Int J Gynecol Pathol; 2006 Apr; 25(2):161-9. PubMed ID: 16633066
[TBL] [Abstract][Full Text] [Related]
20. The thrombin inhibitor Argatroban reduces breast cancer malignancy and metastasis via osteopontin-dependent and osteopontin-independent mechanisms.
Schulze EB; Hedley BD; Goodale D; Postenka CO; Al-Katib W; Tuck AB; Chambers AF; Allan AL
Breast Cancer Res Treat; 2008 Nov; 112(2):243-54. PubMed ID: 18097747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]